BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 11979303)

  • 1. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
    Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C
    Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-kit is expressed by primitive human hematopoietic cells that give rise to colony-forming cells in stroma-dependent or cytokine-supplemented culture.
    Simmons PJ; Aylett GW; Niutta S; To LB; Juttner CA; Ashman LK
    Exp Hematol; 1994 Feb; 22(2):157-65. PubMed ID: 7507857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation.
    Porta C; Caporali R; Epis O; Ramaioli I; Invernizzi R; Rovati B; Comolli G; Danova M; Montecucco C
    Bone Marrow Transplant; 2004 Apr; 33(7):721-8. PubMed ID: 14743200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of W mutant mice provide evidence for alternate mechanisms capable of activating hematopoietic stem cells.
    Miller CL; Rebel VI; Lemieux ME; Helgason CD; Lansdorp PM; Eaves CJ
    Exp Hematol; 1996 Feb; 24(2):185-94. PubMed ID: 8641340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
    Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
    Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
    Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy among erythropoietin, interleukin 3, stem cell factor (c-kit ligand) and interferon-gamma on early human hematopoiesis.
    Kawano Y; Takaue Y; Hirao A; Sato J; Abe T; Suzue T; Saito S; Okamoto Y; Kuroda Y
    Stem Cells; 1994 Sep; 12(5):514-20. PubMed ID: 7528591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
    Manz CY; Nissen C; Wodnar-Filipowicz A
    Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro.
    Cipolleschi MG; D'Ippolito G; Bernabei PA; Caporale R; Nannini R; Mariani M; Fabbiani M; Rossi-Ferrini P; Olivotto M; Dello Sbarba P
    Exp Hematol; 1997 Oct; 25(11):1187-94. PubMed ID: 9328456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of insulin-like growth factor II (IGF-II) and IGF-II mutants specific for IGF-II/CIM6-P or IGF-I receptors on in vitro hematopoiesis.
    Schwartz GN; Warren MK; Sakano K; Szabo JM; Kessler SW; Pashapour A; Gress RE; Perdue JF
    Stem Cells; 1996 May; 14(3):337-50. PubMed ID: 8724700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells.
    Shapiro F; Yao TJ; Moskowitz C; Reich L; Wuest DL; Heimfeld S; McNiece IK; Gabrilove J; Nimer S; Moore MA
    Clin Cancer Res; 1997 Sep; 3(9):1571-8. PubMed ID: 9815845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.
    Sawai N; Koike K; Mwamtemi HH; Ito S; Kurokawa Y; Sakashita K; Kinoshita T; Higuchi T; Takeuchi K; Shiohara M; Kamijo T; Higuchi Y; Miyazaki H; Kato T; Kobayashi M; Miyake M; Yasui K; Komiyama A
    J Leukoc Biol; 2000 Jul; 68(1):137-43. PubMed ID: 10914501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor.
    Johnsen HE; Hansen PB; Plesner T; Jensen L; Gaarsdal E; Andersen H; Hansen SW; Birgens H; Jacobsen GK; Kjaersgaard E
    Bone Marrow Transplant; 1992 Sep; 10(3):229-34. PubMed ID: 1384899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the progenitor cell population follow recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohammed R
    Exp Hematol; 1997 Jun; 25(6):471-7. PubMed ID: 9197323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
    Balducci E; Azzarello G; Valenti MT; Capuzzo GM; Pappagallo GL; Pilotti I; Ausoni S; Bari M; Rosetti F; Sartori D; Ciappa A; Porcellini A; Vinante O
    Stem Cells; 2003; 21(1):33-40. PubMed ID: 12529549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.